Scinai Immunotherapeutics Financials - Benzinga

Scinai Immunotherapeutics Ltd

SCNINASDAQ

Trade with Public

Trade with Public

$3.22

0.289.52%

At close: Aug 21, 5:00 PM EST

$3.27

0.04761.48%

After Hours: Aug 21, 7:58 PM EST

Stock Split: Scinai Immunotherapeutics Ltd is expected to split Friday, August 21, 2026 with a ratio of 1:10

Overview News Earnings Forecast EventsFinancialsSentiment Compare Stock Report

Scinai Immunotherapeutics Financials

Scinai Immunotherapeutics (SCNI) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Scinai Immunotherapeutics FY EPS $(3.56), Sales $1.311M Up From $658.000K YoY

Scinai Immunotherapeutics (NASDAQ:SCNI) reported quarterly losses of $(3.56) per share. The company reported $1.311 million in sales this quarter. This is a 99.24 percent increase over sales of $658.000 thousand the

Benzinga Newsdesk

PRO
Scinai Revenues For Six Months Ended Jun. 30 $773K vs $284K YoY

Benzinga Newsdesk

PRO
Scinai Immunotherapeutics 2024 Revenue $658K

Benzinga Newsdesk

PRO
Scinai Immunotherapeutics Q3 EPS $0.0021 Up From $(0.002) YoY, Sales $168K

Benzinga Newsdesk

Dow Jumps Over 200 Points; NY Empire State Manufacturing Index Falls In July

Avi Kapoor

PRO
Scinai Immunotherapeutics Q1 EPS $(0.001) Up From $(0.003) YoY

Benzinga Newsdesk